Objective To evaluate the curative effects and side reactions or toxicity of late course accelerated hypofractionated three dimensional conformal radiation therapy(3DCRT)combined with NP concurrent chemotherapy for stage Ⅲ non-small cell lung cancer(NSCLC).

Objective:To evaluate the therapeutic effect of the late course hyperfractionation radiotherapy for brain tumors.

Purpose: A prospective randomized clinical trial was conducted to compare the effect of late course accelerated hyperfractionation(LCAHF) with that of conventional fractionation(CF) in the treatment of nasopharyngeal carcinoma(NPC).

Conclusion:Late course accelerated hyperfractionation with 3-DCRT conformal radiotherapy combined concurrent chemotherapy is effective and well tolerated in the patients with esophageal carcinoma.

Effects of late course accelerated hyperfraction on esophageal carcinoma;

Objective To evaluate the clinical value of late course accelerated hyperfractionation radiotherapy(LCAH) in stage Ⅲ non-small cell lung cancer(NSCLC).

The study of 45 esophageal carcinoa patients treated by late course accelerated fractionation radiotherapy;

Late course accelerated fractionation radiotherapy for advanced squamous cell carcinoma of the lung;

Objective:To discuss the effect in treatment of esophageal carcinoma by late-course accelerated hyperfractionation radiotherapy.

Conclusion Late-course accelerated hyperfractionation radiotherapy plus paclitaxel for locally advanced nasopharyngeal carcinoma have a good short-term efficacy, moderate toxicity; patients can easily tolerate.